Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-08

Clinical Trial Update: Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of switching from timolol to DuoTrav (dorzolamide/timolol fixed-dose combination) in glaucoma patients not adequate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DuoTrav (travoprost; timolol (fixed-dose combination))
  • Timolol (timolol)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2013-07-08